British biotech rebrands as Octavian, seeking to establish new empire after setbacks in 2024
11th February 2025 Uncategorised 0Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as Octavian Therapeutics to align with its “growth ambitions and its transition to a privately held company.”
More: British biotech rebrands as Octavian, seeking to establish new empire after setbacks in 2024
Source: fierce